ArticleEuropean journal of immunology2013

Transgenic expression of survivin compensates for OX40-deficiency in driving Th2 development and allergic inflammation.

Fengyang Lei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.